27
May 2026
Scientists rethink GLP-1 delivery to improve dosing, tolerability, and adherence
The review highlights nanocarriers, microspheres, hydrogels, microneedles, long-acting formulations, and co-formulations as promising but mostly early-stage strategies that still require stronger long-term clinical evidence.